Product Information
OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0810 per EA under NDC 33342017910. Its NADAC has been published 480 times since Jun 14, 2017.
FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342017910
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA204814FDA Approved
4/24/2017
TE Code
AB
On Market Since
4/25/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 480 times since Jun 14, 2017, and over the history we have for it it has declined 97.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0810 per EA |
|---|---|
| All-time high | $3.6921 (Jun 14, 2017) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0825 |
| 52-week low | $0.0732 |
| Median price | $0.1072 |
| Average price | $0.1381 |
| Largest weekly change | -94.5% (Jul 19, 2017) |
| Weeks tracked | 480 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.0810 per EA (NDC 33342017910), effective Aug 19, 2026.
How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 97.8%. It has been tracked across 480 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?
Since Jun 14, 2017, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $3.6921 (Jun 14, 2017), with a median of $0.1072 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 20 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?
OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 33342017910) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.